Literature DB >> 21731826

Cytomegalovirus Reactivation in Ulcerative Colitis Patients.

Minh Nguyen1, Kara Bradford, Xiaolan Zhang, David Q Shih.   

Abstract

Ulcerative colitis (UC) patients are believed to have an increased risk for the colonic reactivation of cytomegalovirus (CMV) infection due to both inherent and iatrogenic factors. Numerous studies and case reports have described CMV infection as complicating the disease course of ulcerative colitis patients; the existing evidence suggests an association between the presence of CMV infection and increased colectomy and mortality rates in UC patients. Whether CMV is nonpathogenic with a tropism towards areas of dysplasia and inflammation in the colon of UC or plays an active role in pathogenesis is still debated. In this paper, we examine the existing evidence for the diagnosis and management of CMV infection in UC patients.

Entities:  

Year:  2011        PMID: 21731826      PMCID: PMC3124815          DOI: 10.1155/2011/282507

Source DB:  PubMed          Journal:  Ulcers        ISSN: 2090-1534


  39 in total

1.  Human cytomegalovirus infection: diagnostic potential of recombinant antigens for cytomegalovirus antibody detection.

Authors:  B Weber; A Berger; H Rabenau
Journal:  J Virol Methods       Date:  2001-08       Impact factor: 2.014

2.  Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan.

Authors:  Masaaki Minami; Michio Ohta; Teruko Ohkura; Takafumi Ando; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

3.  Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus.

Authors:  L Beaugerie; C Cywiner-Golenzer; L Monfort; P M Girard; F Carbonnel; Y Ngô; J Cosnes; W Rozenbaum; J C Nicolas; F P Châtelet; J P Gendre
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-04-15

4.  Cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  R Vega; X Bertrán; M Menacho; E Domènech; V Moreno de Vega; M Hombrados; E Cabré; I Ojanguren; M A Gassull
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

5.  Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.

Authors:  K A Papadakis; J K Tung; S W Binder; L Y Kam; M T Abreu; S R Targan; E A Vasiliauskas
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

6.  Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors.

Authors:  C Söderberg-Nauclér; K N Fish; J A Nelson
Journal:  Cell       Date:  1997-10-03       Impact factor: 41.582

7.  Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis.

Authors:  M Cottone; G Pietrosi; G Martorana; A Casà; G Pecoraro; L Oliva; A Orlando; M Rosselli; A Rizzo; L Pagliaro
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

8.  Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study.

Authors:  Neeraja Kambham; Rohini Vij; Christine A Cartwright; Teri Longacre
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

9.  6-mercaptopurine and inflammatory bowel disease: hidden ground for the cytomegalovirus.

Authors:  L C Hookey; W Depew; A Boag; S Vanner
Journal:  Can J Gastroenterol       Date:  2003-05       Impact factor: 3.522

Review 10.  Cytomegalovirus infection masquerading as an ulcerative colitis flare-up: case report and review of the literature.

Authors:  D G Begos; R Rappaport; D Jain
Journal:  Yale J Biol Med       Date:  1996 Jul-Aug
View more
  15 in total

1.  Cytomegalovirus, inflammatory bowel disease, and anti-TNFα.

Authors:  Sara T Campos; Francisco A Portela; Luís Tomé
Journal:  Int J Colorectal Dis       Date:  2017-01-13       Impact factor: 2.571

2.  Small intestinal perforation caused by cytomegalovirus reactivation after subtotal colectomy for ulcerative colitis: report of a case.

Authors:  Hiroyuki Fujikawa; Toshimitsu Araki; Tadanobu Shimura; Yoshiki Okita; Koji Tanaka; Mikihiro Inoue; Mikio Kawamura; Yasuhiro Inoue; Yasuhiko Mohri; Keiichi Uchida; Masato Kusunoki
Journal:  Clin J Gastroenterol       Date:  2013-02-15

3.  Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status.

Authors:  Toshihiro Inokuchi; Jun Kato; Sakiko Hiraoka; Hideyuki Suzuki; Asuka Nakarai; Tomoko Hirakawa; Mitsuhiro Akita; Sakuma Takahashi; Keita Harada; Hiroyuki Okada; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 4.  Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.

Authors:  Sylvie Pillet; Bruno Pozzetto; Xavier Roblin
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

5.  Bile Acids Act as Soluble Host Restriction Factors Limiting Cytomegalovirus Replication in Hepatocytes.

Authors:  Anna-Kathrin Schupp; Mirko Trilling; Stephanie Rattay; Vu Thuy Khanh Le-Trilling; Katrin Haselow; Jan Stindt; Albert Zimmermann; Dieter Häussinger; Hartmut Hengel; Dirk Graf
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

6.  The impact of primary and persistent cytomegalovirus infection on the progression of acute colitis in a murine model.

Authors:  Jerry L Brunson; Felix Becker; Karen Y Stokes
Journal:  Pathophysiology       Date:  2014-11-18

7.  Assessment of Disease Severity and Role of Cytomegalo Virus Infection in Patients with Ulcerative Colitis.

Authors:  Nobin Babu Kalappurayil; Jino Thomas; Baburajan Mankuni; Varghese Thomas
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  Differential cellular localization of Epstein-Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease.

Authors:  Rachele Ciccocioppo; Francesca Racca; Luigia Scudeller; Antonio Piralla; Pietro Formagnana; Lodovica Pozzi; Elena Betti; Alessandro Vanoli; Roberta Riboni; Peter Kruzliak; Fausto Baldanti; Gino Roberto Corazza
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

9.  Ulcerative colitis: a case of steroid refractory disease.

Authors:  Lennard Lee; Mohammed Majid Akhtar; Anjum Gardezisanjliajk; George Macfaul
Journal:  BMJ Case Rep       Date:  2013-04-29

10.  Cytomegalovirus infection presenting as a colonic mass in a patient with acquired immunodeficiency syndrome.

Authors:  Dhyan Rajan; Robin Jacob; Sadat Rashid; Magdalene Vardaros; Anastasiya Pigal; Wondwossen Gebre; Kaleem Rizvon; Krishnaiyer Subramani; Umeko Takeshige; Paul Mustacchia
Journal:  Int Med Case Rep J       Date:  2011-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.